David Waterson

3.2k total citations
38 papers, 1.2k citations indexed

About

David Waterson is a scholar working on Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Waterson has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 16 papers in Molecular Biology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Waterson's work include Malaria Research and Control (11 papers), Computational Drug Discovery Methods (10 papers) and HIV/AIDS drug development and treatment (10 papers). David Waterson is often cited by papers focused on Malaria Research and Control (11 papers), Computational Drug Discovery Methods (10 papers) and HIV/AIDS drug development and treatment (10 papers). David Waterson collaborates with scholars based in Switzerland, United Kingdom and South Africa. David Waterson's co-authors include Jeremy N. Burrows, Ian Fleming, Didier Leroy, Michael J. Witty, Anthony M. Slater, Adriano Henney, Sarah Brockbank, William L. McPheat, Yassir Younis and Richard A. Pauptit and has published in prestigious journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

David Waterson

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Waterson Switzerland 20 523 393 331 181 178 38 1.2k
Bryan K. S. Yeung United States 18 348 0.7× 332 0.8× 426 1.3× 111 0.6× 141 0.8× 33 1.0k
Tony Fröhlich Germany 16 431 0.8× 381 1.0× 293 0.9× 108 0.6× 116 0.7× 18 1.0k
Paolo Coghi Macao 20 429 0.8× 382 1.0× 288 0.9× 87 0.5× 197 1.1× 75 1.2k
Véronique Sinou France 20 580 1.1× 217 0.6× 424 1.3× 208 1.1× 92 0.5× 51 1.1k
Marco Persico Italy 22 524 1.0× 587 1.5× 209 0.6× 122 0.7× 184 1.0× 59 1.4k
Rebecca Deprez‐Poulain France 24 941 1.8× 733 1.9× 164 0.5× 220 1.2× 144 0.8× 61 1.7k
Juliana L. Asgian United States 8 479 0.9× 685 1.7× 70 0.2× 273 1.5× 95 0.5× 9 1.2k
Amy E. Mercer United Kingdom 13 226 0.4× 316 0.8× 344 1.0× 77 0.4× 161 0.9× 15 806
Simon A. Osborne United Kingdom 20 360 0.7× 628 1.6× 425 1.3× 72 0.4× 165 0.9× 42 1.5k
Roberta Ettari Italy 27 742 1.4× 991 2.5× 494 1.5× 375 2.1× 204 1.1× 93 2.1k

Countries citing papers authored by David Waterson

Since Specialization
Citations

This map shows the geographic impact of David Waterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Waterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Waterson more than expected).

Fields of papers citing papers by David Waterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Waterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Waterson. The network helps show where David Waterson may publish in the future.

Co-authorship network of co-authors of David Waterson

This figure shows the co-authorship network connecting the top 25 collaborators of David Waterson. A scholar is included among the top collaborators of David Waterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Waterson. David Waterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laleu, Benoı̂t, Kelly Rubiano, Tomas Yeo, et al.. (2022). Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2. ChemMedChem. 17(22). e202200393–e202200393. 7 indexed citations
2.
Kokkonda, Sreekanth, Farah El Mazouni, Karen L. White, et al.. (2018). Isoxazolopyrimidine-Based Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Antimalarial Activity. ACS Omega. 3(8). 9227–9240. 24 indexed citations
3.
Hallyburton, Irene, Raffaella Grimaldi, Andrew Woodland, et al.. (2017). Screening a protein kinase inhibitor library against Plasmodium falciparum. Malaria Journal. 16(1). 446–446. 16 indexed citations
4.
Avery, Vicky M., Sridevi Bashyam, Jeremy N. Burrows, et al.. (2014). Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum. Malaria Journal. 13(1). 190–190. 37 indexed citations
5.
Burrows, Jeremy N., Brice Campo, Didier Leroy, et al.. (2013). Antimalarial drug discovery – the path towards eradication. Parasitology. 141(1). 128–139. 69 indexed citations
6.
Savi, Chris De, David Waterson, Andrew R. Pape, et al.. (2013). Hydantoin based inhibitors of MMP13—Discovery of AZD6605. Bioorganic & Medicinal Chemistry Letters. 23(16). 4705–4712. 18 indexed citations
7.
Manach, Claire Le, Christian Scheurer, Diego González Cabrera, et al.. (2013). Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum. Malaria Journal. 12(1). 424–424. 47 indexed citations
8.
Younis, Yassir, Frédèric Douelle, Diego González Cabrera, et al.. (2013). Structure–Activity-Relationship Studies around the 2-Amino Group and Pyridine Core of Antimalarial 3,5-Diarylaminopyridines Lead to a Novel Series of Pyrazine Analogues with Oral in Vivo Activity. Journal of Medicinal Chemistry. 56(21). 8860–8871. 33 indexed citations
9.
Cumming, John G., Justin Bower, David Waterson, et al.. (2012). The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity. Bioorganic & Medicinal Chemistry Letters. 22(12). 3895–3899. 16 indexed citations
10.
Zhang, Yong-Kang, Jacob J. Plattner, Yvonne R. Freund, et al.. (2011). Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles. Bioorganic & Medicinal Chemistry Letters. 22(3). 1299–1307. 43 indexed citations
11.
Zhang, Yong-Kang, Jacob J. Plattner, Eric E. Easom, et al.. (2011). An efficient synthesis for a new class antimalarial agent, 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole. Tetrahedron Letters. 52(30). 3909–3911. 26 indexed citations
12.
Cabrera, Diego González, Frédèric Douelle, Tzu‐Shean Feng, et al.. (2011). Novel Orally Active Antimalarial Thiazoles. Journal of Medicinal Chemistry. 54(21). 7713–7719. 70 indexed citations
13.
Burrows, Jeremy N., Didier Leroy, Julie Lotharius, & David Waterson. (2011). Challenges in Antimalarial Drug Discovery. Future Medicinal Chemistry. 3(11). 1401–1412. 50 indexed citations
14.
Zhang, Yong-Kang, Jacob J. Plattner, Yvonne R. Freund, et al.. (2010). Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agents. Bioorganic & Medicinal Chemistry Letters. 21(2). 644–651. 62 indexed citations
15.
Rowsell, Siân, Claire A. Minshull, Sarah Brockbank, et al.. (2002). Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor. Journal of Molecular Biology. 319(1). 173–181. 211 indexed citations
16.
Brown, George R., Alan J. Foubister, Michael C. Johnson, et al.. (2001). Novel 4-piperidinopyridine inhibitors of oxidosqualene cyclase-lanosterol synthase derived by consideration of inhibitor pKa. Bioorganic & Medicinal Chemistry Letters. 11(16). 2213–2216. 7 indexed citations
17.
Dowell, Robert I., et al.. (1993). 4-Methoxy-2-methyltetrahydropyrans: chiral leukotriene biosynthesis inhibitors, related to ICI D2138, which display enantioselectivity. Journal of Medicinal Chemistry. 36(2). 295–296. 11 indexed citations
18.
Dowell, Robert I., Philip N. Edwards, Stephen J. Foster, et al.. (1992). Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors. Journal of Medicinal Chemistry. 35(14). 2600–2609. 69 indexed citations
19.
Bradbury, Robert H., John S. Major, David A. Roberts, et al.. (1990). 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives. Journal of Medicinal Chemistry. 33(9). 2335–2342. 12 indexed citations
20.
Fleming, Ian, John H. Hill, David Parker, & David Waterson. (1985). Diastereoselectivity in the alkylation and protonation of some β-silyl enolates. Journal of the Chemical Society Chemical Communications. 318–321. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan K. S. Yeung Breakdown of academic impact, for papers by Tony Fröhlich Breakdown of academic impact, for papers by Paolo Coghi Breakdown of academic impact, for papers by Véronique Sinou Breakdown of academic impact, for papers by Marco Persico Breakdown of academic impact, for papers by Rebecca Deprez‐Poulain Breakdown of academic impact, for papers by Juliana L. Asgian Breakdown of academic impact, for papers by Amy E. Mercer Breakdown of academic impact, for papers by Simon A. Osborne Breakdown of academic impact, for papers by Roberta Ettari
Rankless by CCL
2026